Navigation Links
Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions
Date:5/25/2011

dolescents aged 4 to 17 years who have had an inadequate response to, or who have proved intolerant of, methotrexate.  ENBREL has not been studied in children aged less than 4 years.
  • Psoriatic arthritis: Treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug therapy has been inadequate.  ENBREL has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease.
  • Ankylosing spondylitis: Treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.
  • Plaque psoriasis: Treatment of adults with moderate to severe plaque psoriasis who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapy including cyclosporine, methotrexate or PUVA.  The European Commission recently approved a new 50mg ENBREL once-weekly dosage regimen as an alternative to the currently approved 25mg ENBREL twice-weekly regimen for the treatment of patients with moderate-to-severe plaque psoriasis.
  • Pediatric plaque psoriasis: Treatment of chronic severe plaque psoriasis in children and adolescents from the age of 8 years who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.

  • For full information about ENBREL go to: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000262/WC500027364.pdf

    Important Safety InformationSerious infections, including sepsis and tuberculosis, have been reported with the use of ENBREL.  Some of these infections have been fatal.  These infections wer
    '/>"/>

    SOURCE Amgen
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
    3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
    4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
    5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
    6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
    7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
    8. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
    9. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
    10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
    11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/1/2015)... The global Bioinformatics ... sectors, products & services and application. And the rising ... increasing demand of advanced drugs for the diagnosis ... growth for bioinformatics market. The implementation of information ... as bioinformatics. Decreasing cost of DNA sequencing, continuous ...
    (Date:9/1/2015)... Research and Markets ( http://www.researchandmarkets.com/research/r8v22b/regulatory ) has announced the ... (London, UK - September 24-25, 2015)" conference to ... provides an introduction to Pharmaceutical Regulatory Affairs and the ... for those working in a support staff role. ... regulatory procedures required to register products in ...
    (Date:9/1/2015)... , September 1, 2015 - ... GARFIELD-AF R egistry data presented at ... on the evolution of manag ... -   The first-ever two-year outcomes from ... ESC Congress 2015 expose that all-cause death was the most frequent major event ...
    Breaking Medicine Technology:Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4Regulatory Affairs for Support Staff Seminar (London, UK - September 24-25, 2015) 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 3Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 4Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 5Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 7Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 8Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 9
    (Date:9/1/2015)... Los Angeles, CA (PRWEB) , ... September 01, 2015 , ... ... the American Medical Association, individuals with type 2 diabetes that participated in a three ... of diabetes three years down the line if they elected weight loss surgery at ...
    (Date:9/1/2015)... , ... September 01, 2015 , ... From Aug. 17-21, ... and teenagers, from ages 6-18. Calvary’s Camp Compass® has taken place at Kingsborough Community ... 65 adult counselors, some of whom work for Calvary, and two junior counselors who ...
    (Date:9/1/2015)... ... September 01, 2015 , ... Consumers overwhelmingly prefer to ... Dermatologic Surgery, according to a new survey that also offers insight on why ... Procedures – which reflects views on cosmetic medical treatments and ratings for 10 ...
    (Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN in ... MonaLisa Touch® , an innovative vaginal health laser procedure that prevents and resolves ... treatment for atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, painful ...
    (Date:9/1/2015)... NC (PRWEB) , ... September 01, 2015 , ... With ... Technology, Engineering and Math) disciplines since its inception more than 35 years ago. A ... high-school students and their teachers - and, not just those intent on pursuing careers ...
    Breaking Medicine News(10 mins):Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2
    ... poor supervisors to higher odds for heart attack , FRIDAY, Nov. ... is ruining your workday, you may be taking that stress to ... a higher risk of heart attack, and that,s not all: people ... The findings, which come from surveys of thousands of employees in ...
    ... year,s 23rd annual Great Chefs of Los Angeles (GCLA) ... a bounty of great-tasting organic snacks and beverages, all ... manufacturer of organic earth-friendly, extraordinary products that help preserve ... its premium, organic coffees, handpicked fair-trade mate teas, 100% ...
    ... accounts for better motor skills later, study suggests, , ... deprived of oxygen at birth often go on to ... infants can help prevent problems. , Now, a new ... of brain lesions in the babies. , Oxygen ...
    ... Nov. 6 Lippincott Williams & Wilkins is proud ... Professionals Need to Know About Sexual and Gender Diversity, ... DNSc, RN, Jeanne DeJoseph, CNM, PhD, and Peggy Chinn, ... www.NursingCenter.com/lgbtq and addresses health care disparities among the gay, ...
    ... ... recently released World Alzheimer Report declares that more than 35 million people worldwide will ... 16 independent living and assisted living, and Alzheimer,s/memory care communities in Wisconsin and Illinois, ... disease. , ...
    ... Nov. 5 The following was released today by Randall Terry: ... inside or outside in the hall at Nancy Pelosi,s office, #235 ... of the bill - all 2,000 pages (4,000) - and proceeded ... the floor. , Approximately 150 supporters were in the hall, chanting: ...
    Cached Medicine News:Health News:Can a Bad Boss Make You Sick? 2Health News:Explorer's Bounty Contributing Charitable Bounty to Great Chefs of Los Angeles Event 2Health News:New E-Book Addresses LGBTQ Issues in the Education of Healthcare Professionals 2Health News:New E-Book Addresses LGBTQ Issues in the Education of Healthcare Professionals 3Health News:Top 10 Ways to Prevent or Delay Alzheimer's 2
    Used to negotiate tortuous vessels....
    BiodivYsio stent with biocompatible coating (phosphorylcholine)...
    ... The CYPHER Sirolimus-eluting Coronary Stent ... drug, called "sirolimus", a controlled-release ... delivery platform. Upon placement, sirolimus ... and impedes the process of ...
    PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig...
    Medicine Products: